Crossmark

Low-dose pembrolizumab induced complete radiologic and molecular response of posttransplant lymphoproliferative disorder presenting as classical Hodgkin lymphoma

Crossref DOI link: https://doi.org/10.1007/s00277-019-03856-y

Published Online: 2019-11-26

Published Print: 2020-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sim, Joycelyn P. Y.

Au-Yeung, Rex

Kwong, Yok-Lam https://orcid.org/0000-0001-8156-6978
License Information

Text and Data Mining valid from 2019-11-26

Version of Record valid from 2019-11-26
More Information

Article History

Received: 21 October 2019

Accepted: 18 November 2019

First Online: 26 November 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: Patient gave informed consent to treatment.

Document is current

Any future updates will be listed below